Eye-tracking Training for Older Adults
Eye Tracking as an Early Cognitive Intervention for Older Adults With Subjective Memory Complaints
The goal of this clinical trial is to learn if a computerized eye-tracking training program can improve mental health and thinking skills in older adults. The main questions it aims to answer are whether eye-tracking training can lower depressive and anxiety symptoms in older adults, and whether it can improve their ability to control impulses and pay attention.
Researchers will compare older adults who receive eye-tracking training to older adults on a waitlist to see if eye-tracking training leads to greater improvements in mood and thinking skills.
Researchers will randomly assign participants into the experimental group or the waitlist control group. Participants in the experimental group will take part in eye-tracking training three times a week for 18 sessions, over about 1.5 months. Before and after training, participants will answer questions about their mood and take tests of memory, attention, and impulse control. Older adults on the waitlist will complete the same tests but will not receive training until after the study period; they will be offered the same training once their waiting period ends.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Hong Kong, Hong Kong, 0000
- Research Center for Neuropsychological Well-being
-
Hong Kong, Hong Kong
- International Women's League Neighbourhood Elderly Centre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Community-dwelling Chinese older adults aged 60 to 80 years
- Able to understand Cantonese/Chinese
- Normal or corrected-to-normal vision
- Willing and able to commit to attending 18 training sessions over the course of the intervention
Exclusion Criteria:
- A history of learning disability, psychiatric disorders, neurological disorders (e.g., head injury or Parkinson's disease), visual and/or hearing impairments, or any other physical disabilities that would affect their performance on neuropsychological assessment or adherence to the intervention
- Prior or concurrent participation in other interventions involving eye-tracking techniques
- Signs of dementia, as indicated by a total score of 18 or below on the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA)
- Inability to commit to the full course of 18 training sessions
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Eye-Tracking Training
Participants receive computerized eye-tracking training for 18 one-hour sessions, three times weekly, over approximately 6 weeks.
|
The intervention is a copyrighted computerized training program using a non-contact eye tracker.
Participants are required to fixate on or trace visual targets across six modules of increasing difficulty to improve attention and inhibitory control.
|
|
Ingen inngripen: Waitlist control
Participants in this group do not receive eye-tracking training during the study period and complete the same baseline and post-assessment schedule as the experimental group.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Inhibitory control
Tidsramme: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Inhibitory Control Index (ICI) in the Eriksen Flanker Test
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Sustained attention
Tidsramme: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Digit Cancellation Index (DCI) in the Digit Cancellation Test
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Depressive symptoms
Tidsramme: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Depressive symptoms are assessed using the 15-item Chinese version of Geriatric Depressive Scale (CGDS-15).
It is a 15-item self-report scale in which participants answer "Yes" or "No" to whether they experienced each of 15 common depressive symptoms in the past week.
Scores range from 0 to 15, with higher scores indicating more depressive symptoms.
A score of 8 or higher indicates clinically significant depressive symptoms.
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Anxiety symptoms
Tidsramme: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Anxiety symptoms are assessed using the 10-item Chinese version of Geriatric Anxiety Scale (CGAS-10).
It is a 10-item self-report measure of anxiety symptoms in older adults.
Higher scores indicate greater severity of anxiety symptoms.
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2022.625
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .